0000950170-24-073042.txt : 20240613 0000950170-24-073042.hdr.sgml : 20240613 20240613162102 ACCESSION NUMBER: 0000950170-24-073042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240611 FILED AS OF DATE: 20240613 DATE AS OF CHANGE: 20240613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nemirovsky Julian CENTRAL INDEX KEY: 0001835535 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38436 FILM NUMBER: 241041506 MAIL ADDRESS: STREET 1: 35 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC CENTRAL INDEX KEY: 0001010086 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 133864870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-672-9100 MAIL ADDRESS: STREET 1: 31 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961108 4 1 ownership.xml 4 X0508 4 2024-06-11 false 0001010086 SIGA TECHNOLOGIES INC SIGA 0001835535 Nemirovsky Julian C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065 true false false false false Common Stock, par value $.0001 per share 2024-06-11 4 M false 24712 A 50928 D Common Stock, par value $.0001 per share 2024-06-11 4 D false 7414 7.86 D 43514 D Restricted Stock Units 2024-06-11 4 M false 24712 0 D Common Stock, par value $.0001 per share 24712 0 D Restricted Stock Units 2024-06-11 4 A false 19084 0 A Common Stock, par value $.0001 per share 19084 19084 D Restricted stock units ("RSUs") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the "Company") on a one-for-one basis. Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 15, 2023. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs. The RSUs were granted on June 13, 2023, and fully vested on the date of the Company's 2024 annual meeting of stockholders. RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 5,725 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors. The RSUs fully vest on the date of the Company's 2025 annual meeting of stockholders. /s/ Kevin Buckley, as Attorney-in-Fact 2024-06-13